Regarding the molecular mechanism, the authors provided evidence that CRH acts on ovarian cancer through CRHR1, which upregulates the expression of Fas ligands (FasL), potentiating the ability to induce Fas-mediated apoptosis. This evidence concerns the gene CRHR1 and ovarian cancer.